Related Experiment Videos
Cardiovascular complications in diabetes mellitus
Burton E Sobel1, David J Schneider
1University of Vermont, Colchester, VT 05446, USA.
Current Opinion in Pharmacology
|March 23, 2005
Summary
Diabetes significantly increases the risk of arterial diseases and heart failure due to hormonal and metabolic issues. Intensive, multi-targeted therapy is crucial but often underutilized in managing diabetic cardiovascular complications.
Area of Science:
- Cardiovascular Medicine
- Endocrinology
- Diabetology
Background:
- Diabetes mellitus is a major risk factor for macrovascular complications, including coronary, cerebral, and peripheral arterial diseases.
- Diabetic patients exhibit increased atherosclerotic plaque vulnerability and microangiopathy.
- Hormonal (e.g., insulin resistance) and metabolic derangements are key contributors to diabetes-related vascular damage.
Purpose of the Study:
- To highlight the significant association between diabetes and various arterial diseases.
- To emphasize the underutilization of essential multi-targeted intensive therapies in diabetic patients.
- To underscore the link between diabetes, impaired arterial/ventricular compliance, and congestive heart failure.
Main Methods:
- Review of existing literature on diabetes and cardiovascular complications.
- Analysis of the contribution of hormonal and metabolic abnormalities.
- Examination of functional and structural changes predisposing to heart failure.
Main Results:
- Diabetes is strongly linked to coronary, cerebral, and peripheral arterial disease, alongside microangiopathy.
- Atherosclerotic plaques in diabetic individuals are more prone to rupture.
- Impaired arterial and ventricular compliance in diabetics contributes to congestive heart failure.
Conclusions:
- Diabetic cardiovascular complications, including heart failure, represent a significant cause of morbidity and mortality.
- Multi-targeted intensive therapy is imperative for managing these complications but is underutilized.
- Addressing hormonal and metabolic derangements is critical for mitigating diabetic cardiovascular risk.